A new study suggests excessive daytime sleepiness in obstructive sleep apnea may be associated with cognitive impairment and ...
A global, randomized, double-blind phase 3 program in ~150 DM1 patients dosed every 8 weeks did not significantly improve vHOT, a hand myotonia endpoint, versus placebo. Secondary endpoints included ...
A 72% prevalence of excessive daytime sleepiness was identified using PDSS ≥15 among 1,616 adolescents aged 14–19 years in 20 ...
NeurologyLive Brain Games is a weekly quiz series that goes live every Sunday morning, featuring questions on a variety of ...
A lymphocyte-count polygenic score derived from Pan-UK Biobank GWAS data was inversely associated with grade 2 lymphopenia ...
Findings from a new study showed that over 90% of counties in the United States lacked a UCNS-certified headache specialist, ...
The American Heart Association (AHA) and American Stroke Association (ASA) have published the "2026 Guideline for Adult ...
Progressive supranuclear palsy (PSP) is a rare, progressive neurodegenerative disorder characterized by parkinsonism ...
Episode 174 of the NeurologyLive ® Mind Moments ® podcast is now live! Scroll down to listen or click here to subscribe on ...
KINECT-PRO enrolled distressed adults with TD and schizophrenia-spectrum or mood disorders; flexible valbenazine dosing (40–80 mg) produced sustained improvements across patient-reported and clinician ...
Zanvastro (zilganersen) is approved for the treatment of Alexander disease in pediatric and adult patients, and is the first ...